Back to Blog

Supplements for Parkinson's Support: CoQ10, Mucuna, and Antioxidants

February 26, 2026·4 min read

Parkinson's disease is characterized by the progressive loss of dopamine-producing neurons in the substantia nigra and the accumulation of alpha-synuclein protein aggregates. While no supplement reverses Parkinson's, several compounds target the underlying mitochondrial dysfunction, oxidative stress, and dopamine depletion that drive the disease.

CoQ10 (Coenzyme Q10)

Mitochondrial dysfunction is one of the earliest and most consistent findings in Parkinson's disease. CoQ10, a critical component of the mitochondrial electron transport chain, is significantly depleted in the brains and platelets of Parkinson's patients.

Early clinical trials were promising — a phase II trial found that 1,200 mg/day of CoQ10 slowed functional decline compared to placebo over 16 months. However, the larger QE3 trial at 1,200-2,400 mg/day did not show significant benefit, suggesting CoQ10 may be more useful as a preventive strategy or early-stage support.

Dosage: 300-1,200 mg/day of ubiquinol form (better absorbed than ubiquinone). Take with fat-containing meals.

Mucuna Pruriens

Mucuna pruriens is a legume that contains naturally occurring L-DOPA, the same compound in the primary Parkinson's medication levodopa. Unlike synthetic levodopa, Mucuna also contains several co-factors that may influence dopamine metabolism more broadly.

Pilot studies comparing Mucuna to pharmaceutical levodopa found comparable improvements in motor function with potentially fewer dyskinesias, though larger trials are needed. Mucuna is not a replacement for prescribed medications but may complement them.

Dosage: 15-60% L-DOPA standardized extract; dosing is complex and should be supervised by a physician familiar with Parkinson's management.

NADH

NADH (nicotinamide adenine dinucleotide) serves as a cofactor for dopamine synthesis and supports mitochondrial energy production. Several small open-label trials reported motor improvements with IV or oral NADH in Parkinson's patients.

A controlled trial found significant improvements in disability scale scores with oral NADH over 4 weeks compared to placebo. While the evidence base is small, NADH has a favorable safety profile.

Dosage: 5-10 mg/day of stabilized NADH taken on an empty stomach.

Vitamin D

Parkinson's patients consistently show lower vitamin D levels than age-matched controls, and low vitamin D at baseline predicts faster disease progression. Vitamin D receptors are expressed in the substantia nigra, and animal studies show vitamin D protects dopaminergic neurons.

Dosage: 2,000-5,000 IU/day; test serum 25(OH)D levels and target 40-60 ng/mL.

Glutathione

Glutathione is the brain's master antioxidant, and levels in the substantia nigra are severely depleted in Parkinson's. Oral glutathione has poor bioavailability, but liposomal glutathione, N-acetylcysteine (NAC, a precursor), and whey protein can meaningfully raise brain glutathione.

IV glutathione infusions have shown anecdotal benefit in small open-label studies, but evidence remains limited. NAC at 600-1,800 mg/day is a more accessible approach.

Dosage: NAC 600-900 mg twice daily, or liposomal glutathione 500-1,000 mg/day.

FAQ

Q: Can supplements be taken alongside Parkinson's medications? A: Some supplements interact with levodopa — Mucuna in particular should only be added under medical supervision. High-dose vitamin B6 can block levodopa's effects and should be avoided. Always consult your neurologist before adding supplements.

Q: How early should someone start supplementing for Parkinson's prevention? A: Given that Parkinson's pathology begins 10-20 years before symptoms, mitochondrial support (CoQ10, NAC) and anti-inflammatory lifestyle practices are reasonable preventive measures for those with family history or early warning signs like REM sleep behavior disorder or loss of smell.

Q: What lifestyle factors most complement supplementation for Parkinson's? A: Vigorous aerobic exercise has the strongest evidence for neuroprotection in Parkinson's, potentially even slowing dopaminergic cell loss. Combined with targeted supplementation, exercise is the most powerful tool available.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free